Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA
Trial details
- Registry ID
- NCT05667662
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as PUR1900
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPANCT05667662 | PULM | Phase 2 | Terminated | 2024-02-27Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |